Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inpatient Penicillin Allergy Delabeling Pilot
NCT05020327Phase 4Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Sep 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of amoxicillin in penicillin allergy (3 arms), sponsored by University Hospitals Cleveland Medical Center. Primary endpoint: Number of Participants With Confirmed Allergy Status at 3 hours. Started Sep 2021; status: completed.
02
Drugs
amoxicillin
03
Conditions
penicillin allergy
Beyond the preview
Go deeper on NCT05020327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05020327.